Results suggest that molecular subtyping may help in selecting patients who could benefit most from NAC, and patients who could be best managed with surgery alone.
This multi-institutional series analyses early recurrence patterns among patients undergoing robot-assisted radical cystectomy for bladder cancer.
Our study suggests the possibility of androgen suppression therapy as prophylaxis for intravesical recurrence of bladder cancer. Further explorations are warranted of the prophylactic effect of androgen suppression therapy on bladder cancer pathogenesis.
